A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins

Completed · Not applicable

Conditions studied: Breast Cancer

In brief

The goal of this research is to further develop novel optical assay systems for intra operative assessment of tumor margins in partial mastectomy or mastectomy specimens.

Key facts

Study ID

NCT01372631

Run by

Duke University

People needed

218

Starts

2011-04-01

Expected to finish

2017-04-01

Last updated by the study team

2021-02-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing a reduction mammoplasty OR
• Patients undergoing a lumpectomy mastectomy for the treatment of an invasive or non-invasive breast malignancy
• Age > 18
• Clinically detectable disease either by physical examination or radiographic studies
• Patients of all ethnic and gender groups will be included. Protocol accrual will be reviewed annually to include a determination of minority and gender representation. If accrual demonstrates under-representation of any group with comparison to disease incidence in that group, appropriate measures will be undertaken to increase participation of patients of that minority or gender group
• Ability to understand and the willingness to sign a written informed consent document.

You may not qualify if…

• Patients considered in "vulnerable" populations.

Where it is running

• Duke University Medical Center — Durham, North Carolina, United States
• University of Wisconsin - Madison — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.